Neonatal Symptoms After In Utero Exposure to SSRIs - MGH Center

The increasing number of reproductive-age women taking antidepressants has raised concerns about the potential risks of using these medications during pregnancy. Literature accumulated over the last decade supports the use of certain selective serotonin reuptake inhibitors (SSRIs) and the older tricyclic antidepressants during pregnancy, indicating no increased risk of congenital malformation in children exposed to these medications during the first trimester of pregnancy. Still, questions remain regarding the purported risk for "toxicity" in newborns exposed to antidepressants around the time of labor and delivery. These concerns are not new. Twenty years ago, case reports suggested that maternal use of tricyclic antidepressants near the time of delivery was associated with problems in the newborn such as difficulty feeding, restlessness, or jitteriness.

Neonatal Abstinence Syndrome PDF Version of Slides

Characteristics of toxicity versus withdrawal in infants exposed to

Antidepressants During Breastfeeding - Psychopharmacology Institute

Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study, Child and Adolescent Psychiatry and Mental Health

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database, Psychological Medicine

PDF) Length of prenatal exposure to selective serotonin reuptake inhibitor ( SSRI) antidepressants: Effects on neonatal adaptation and psychomotor development

Depression, obesity and their comorbidity during pregnancy: effects on the offspring's mental and physical health

Table 2 from Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

JCM, Free Full-Text